Skip to main content

Chief Administrative Officer of PERFORM Centre named

Kevin Little returns to Montreal after seven years of bioscience industry development in New Zealand.
June 21, 2011
|
By Anne-Marie Curatolo


Kevin Little has been named Chief Administrative Officer of Concordia University’s Prevention, Evaluation, Rehabilitation, Formation (PERFORM) Centre, effective June 13, 2011.

Through research, education and community engagement, the centre will bring together disease-prevention efforts involving exercise, physical activity, nutrition and behaviour change to improve health.

Kevin Little is the new Chief Administrative Officer of Concordia University’s Prevention, Evaluation, Rehabilitation, Formation (PERFORM) Centre. | Photo by Concordia University
Kevin Little is the new Chief Administrative Officer of Concordia University’s Prevention, Evaluation, Rehabilitation, Formation (PERFORM) Centre. | Photo by Concordia University

“We’re being given a unique opportunity through the creation of PERFORM to become the centre of excellence in the promotion and delivery of comprehensive health science,” explains Little. “PERFORM offers an unprecedented resource to attract precisely the kinds of research, teaching and community health partnerships many of us have always dreamed of. I can’t imagine a richer foundation upon which to build.”

Little joins Concordia after spending seven years in New Zealand, where he led the government’s economic development and investment promotion activities in healthcare and bioscience. He is also co-founder of the Asia Collaborative Business Community, a group devoted to building strategic alliances and collaborative best practices across diverse cultures and industries.

He has completed his post-doctoral fellowship in the Faculty of Medical and Health Sciences at the University of Auckland in New Zealand and holds a PhD in Experimental Medicine from McGill University. Little’s extensive research background focuses on the complex interactions between environment, disease, genetics and behaviour. Examples of his studies include human DNA repair in cancer, treatment of the adverse cognitive impacts of cancer chemotherapy, and the development of vaccines for stroke, epilepsy and addiction.

“Dr. Little complements and adds important strengths to my executive team. His background as a medical researcher, his experience developing partnerships across medical, academic, governmental and business sectors, his quick grasp of PERFORM’s mission and operations, will be invaluable to us as we move forward to realize the full potential of the PERFORM Centre at Concordia University,” says Brian Lewis, dean of the Faculty of Arts and Science.

Related links:
•    PERFORM Centre
•    “Peak Performance” - NOW, May 11, 2011
•    “PERFORM Centre on Track” - Journal, November 8, 2010



Back to top

© Concordia University